nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A blueprint for the worldwide research response to dementia
|
Cataldi, Rodrigo |
|
|
21 |
8 |
p. 690-691 |
artikel |
2 |
Andreas Charidimou
|
|
|
|
21 |
8 |
p. 689 |
artikel |
3 |
Antibiotic neuromuscular junction myasthenic mimetics
|
Uzoigwe, Chika Edward |
|
|
21 |
8 |
p. 681 |
artikel |
4 |
Antibiotic neuromuscular junction myasthenic mimetics – Authors' reply
|
Huijbers, Maartje G |
|
|
21 |
8 |
p. 681 |
artikel |
5 |
Cerebral amyloid angiopathy criteria: the next generation
|
Graff-Radford, Jonathan |
|
|
21 |
8 |
p. 674-676 |
artikel |
6 |
Cognitive-motor dissociation and time to functional recovery in patients with acute brain injury in the USA: a prospective observational cohort study
|
Egbebike, Jennifer |
|
|
21 |
8 |
p. 704-713 |
artikel |
7 |
Diagnosis and treatment of orthostatic hypotension
|
Wieling, Wouter |
|
|
21 |
8 |
p. 735-746 |
artikel |
8 |
Exercise training and neuroprotection in multiple sclerosis
|
Hvid, Lars G |
|
|
21 |
8 |
p. 681-682 |
artikel |
9 |
Further support for rituximab in relapsing multiple sclerosis
|
Naismith, Robert T |
|
|
21 |
8 |
p. 672-673 |
artikel |
10 |
Improving prognostication after severe brain injury
|
OBE, Adrian M Owen |
|
|
21 |
8 |
p. 673-674 |
artikel |
11 |
Interferon receptor dysfunction in a child with malignant atrophic papulosis and CNS involvement
|
Becker, Lena-Luise |
|
|
21 |
8 |
p. 682-686 |
artikel |
12 |
Linda de Vries: intervening early to improve young lives
|
Samarasekera, Udani |
|
|
21 |
8 |
p. 688 |
artikel |
13 |
Major advances in sleep neurology: 2002–22
|
Scammell, Thomas E |
|
|
21 |
8 |
p. 678-680 |
artikel |
14 |
Moyamoya disease: diagnosis and interventions
|
Ihara, Masafumi |
|
|
21 |
8 |
p. 747-758 |
artikel |
15 |
Safety and efficacy of rituximab versus dimethyl fumarate in patients with relapsing-remitting multiple sclerosis or clinically isolated syndrome in Sweden: a rater-blinded, phase 3, randomised controlled trial
|
Svenningsson, Anders |
|
|
21 |
8 |
p. 693-703 |
artikel |
16 |
Tau biomarkers in Alzheimer's disease: towards implementation in clinical practice and trials
|
Ossenkoppele, Rik |
|
|
21 |
8 |
p. 726-734 |
artikel |
17 |
The Boston criteria version 2.0 for cerebral amyloid angiopathy: a multicentre, retrospective, MRI–neuropathology diagnostic accuracy study
|
Charidimou, Andreas |
|
|
21 |
8 |
p. 714-725 |
artikel |
18 |
The drive and determination of John Hughlings Jackson
|
Wijdicks, Eelco |
|
|
21 |
8 |
p. 692 |
artikel |
19 |
The importance of genomics in advancing the diagnosis and treatment of dementia
|
Decourt, Boris |
|
|
21 |
8 |
p. 676-677 |
artikel |
20 |
Time to revise primary prevention guidelines for stroke and cardiovascular disease
|
Brainin, Michael |
|
|
21 |
8 |
p. 686-687 |
artikel |
21 |
West Syndrome and the new classification of epilepsy
|
Knight, Elia M Pestana |
|
|
21 |
8 |
p. 689 |
artikel |
22 |
WHO launches its Global Action Plan for brain health
|
The Lancet Neurology, |
|
|
21 |
8 |
p. 671 |
artikel |